Patents by Inventor Yaguang Liu

Yaguang Liu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4945115
    Abstract: A new pharmaceutical composition for treatment and prevention of side effects of anticancer chemotherapy and radiotherapy and increasing the immune function contains Ferulic acid, Ginsenoside, Anethole and sodium Cinnamate. Processes for producing these components and related pharmacological effect are provided.
    Type: Grant
    Filed: June 18, 1987
    Date of Patent: July 31, 1990
    Inventor: Yaguang Liu
  • Patent number: 4906470
    Abstract: The new pharmaceutical composition (PTC) and process are provided for treating and preventing cardiovascular disease.The fine-PTC is composed of following ingredients: Puerarin or derivative of Puerarin; Danshensu or Danshenketone; Tetramethyl pyrazine; Polysaccharides and Saponin of Dangshen.The composition is nontoxic.
    Type: Grant
    Filed: September 22, 1986
    Date of Patent: March 6, 1990
    Inventor: Yaguang Liu
  • Patent number: 4906471
    Abstract: The new pharmaceutical compositions and processes are provided for reducing both hyperlipidemia and platelet-aggregation (PHP).The fine-PHP is composed of following ingredients: Scoparone or Aurapten, Curcumin, Ferulic Acid, Yejuhua-flavonoid and additive ingredient--fish oil. The compositions are nontoxic.
    Type: Grant
    Filed: March 8, 1989
    Date of Patent: March 6, 1990
    Inventor: Yaguang Liu
  • Patent number: 4886666
    Abstract: A safe pharmaceutical composition for treatment and prevention of infections caused by viruses and increasing immune function. The pharmaceutical composition is composed of four active ingredients: Polysaccharides of Wang Qi, Banlankensu, Yejuhua-flavonoid and Guanzhongsu and method of making the same.
    Type: Grant
    Filed: January 27, 1987
    Date of Patent: December 12, 1989
    Inventor: Yaguang Liu
  • Patent number: 4843067
    Abstract: A new pharmaceutical composition is composed of two plant extracts: Polysaccharides of Hunang QI and Polysaccharides of Dankuei. The pharmaceutical composition is highly effective in increasing immune function and is very safe. Methods of extracting polysaccharides of Huang QI from Astragalus membranaceus Bge or Astragalus gummifier Labillard, and polysaccharides of Dankuei from Angelica sinensis Diels, Angelic archangelica or Levisticum officinale Koch are disclosed.
    Type: Grant
    Filed: November 19, 1986
    Date of Patent: June 27, 1989
    Inventor: Yaguang Liu
  • Patent number: 4842859
    Abstract: The new pharmaceutical compositions and processes are provided for reducing both hyperlipidemia and platelet-aggregation (PHP).The fine-PHP is composed of following ingredients: Scoparone or Aurapten, Curcumin, Ferulic Acid, Yejuhua-flavonoid and additive ingredient--fish oil. The compositions are nontoxic.
    Type: Grant
    Filed: September 8, 1986
    Date of Patent: June 27, 1989
    Inventor: Yaguang Liu
  • Patent number: 4808629
    Abstract: A new pharmaceutical composition for treating nonlymphatic leukemia, such as granulocytic and monocytic leukemia comprising Harringtonine, Homoharringtonine, Anethole, Oleanolic acid and Ginsenoside and method of making the same.
    Type: Grant
    Filed: May 14, 1987
    Date of Patent: February 28, 1989
    Inventor: Yaguang Liu
  • Patent number: 4795742
    Abstract: Therapeutic compositions are composed of four plant extracts: ginsenoside, tetramethyl pyrazine, astragalan and atractylol. Pharmaceutical dosage units are prepared by conventional means with specific weight ranges and proportions of each of the four ingredients. The pharmaceutical dosage units are highly effective in treating cerebral vascular disease and the sequelae thereof. The dosage units are also useful for bolstering immunofunction in healthy and diseased patients.
    Type: Grant
    Filed: October 14, 1986
    Date of Patent: January 3, 1989
    Inventor: Yaguang Liu
  • Patent number: 4783454
    Abstract: A new pharmaceutical composition for treating nonlymphatic leukemia, such as granulocytic and monocytic leukemia comprising Harringtonine, Homoharringtonine, Anethole, Oleanolic acid and Ginsenoside and method of making the same.
    Type: Grant
    Filed: May 14, 1987
    Date of Patent: November 8, 1988
    Inventor: Yaguang Liu
  • Patent number: 4755504
    Abstract: A pharmaceutical composition containing saponin and quercetin, derived from Tienchi, is effective in treatment of circulatory disease and as health food. Processes for producing these components are provided.
    Type: Grant
    Filed: December 22, 1986
    Date of Patent: July 5, 1988
    Inventor: Yaguang Liu
  • Patent number: 4708949
    Abstract: Therapeutic compositions are composed of four plant extracts: ginsenoside, tetramethyl pyrazine, astragalan and atractylol. Pharmaceutical dosage units are prepared by conventional means with specific weight ranges and proportions of each of the four ingredients. The pharmaceutical dosage units are highly effective in treating cerebral vascular disease and the sequelae thereof. The dosage units are also useful for bolstering immunofunction in healthy and diseased patients.
    Type: Grant
    Filed: September 24, 1985
    Date of Patent: November 24, 1987
    Inventor: Yaguang Liu
  • Patent number: 4687761
    Abstract: A new pharmaceutical composition for treatment and prevention of side effects of anticancer chemotherapy and radiotherapy and increasing the immune function contains Ferulic acid, Ginsenoside, Anethole and sodium Cinnamate. Processes for producing these components and related pharmacological effect are provided.
    Type: Grant
    Filed: May 9, 1985
    Date of Patent: August 18, 1987
    Inventor: Yaguang Liu
  • Patent number: 4684628
    Abstract: A new pharmaceutical composition for treatment and prevention of cardiovascular disease, and increasing immune function contains Ginsenoside, Ophiopogonin, Sesquicarene and Chamigrene. Processes for producing these components and the composition, referred to as Pure San-Mai-Sen (PSMS), are provided.
    Type: Grant
    Filed: May 3, 1985
    Date of Patent: August 4, 1987
    Inventor: Yaguang Liu
  • Patent number: 4675318
    Abstract: A new pharmaceutical composition for treating nonlymphatic leukemia, such as granulocytic and monocytic leukemia comprising Harringtonine, Homoharringtonine, Anethole, Oleanolic acid and Ginsenoside and method of making the same.
    Type: Grant
    Filed: May 28, 1985
    Date of Patent: June 23, 1987
    Inventor: Yaguang Liu